F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 1 filers reported holding F-STAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,788,992 | +23.4% | 599,524 | 0.0% | 0.46% | +34.5% |
| Q3 2022 | $3,070,000 | -18.2% | 599,524 | 0.0% | 0.34% | -45.9% |
| Q2 2022 | $3,753,000 | +76.4% | 599,524 | 0.0% | 0.63% | +133.1% |
| Q1 2022 | $2,128,000 | -29.3% | 599,524 | 0.0% | 0.27% | -2.5% |
| Q4 2021 | $3,010,000 | – | 599,524 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |